Churchill Capital Corp III
Status: Deal Closed
U=S+W/4
W=S@11.5
| IPO Proceeds, $M | $1,100.00M |
|---|---|
| IPO Date | Feb 14, 2020 |
| CEO | Michael Klein |
| Left Lead | Citigroup |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24+3 |
| IPO Sector |
General
Not specified |
| IPO Geography | Global |
| Target Company | MultiPlan |
| Deal Announced | Jul 12, 2020 |
| Deal Size, $M | $11,138.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Oct 7, 2020 |
| Amendment Vote | TBD |
| Closing Date | Oct 8, 2020 |
Formerly CCXX
MPLN
MPLN/W
| Price | $7.00 $0.18 |
|---|---|
| Last closing price | $7.97 |
| H/L, 52-week | $0.61 / $2.68 |
| Volume, today | 62,818 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Churchill Capital Corp III:
- Structure and cap table
- 9 directors & officers
- 33 filings and events
- 3 underwriters
- 9 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Michael Klein | 56 | Chief Executive Officer, President and Chairman of the Board of Directors |
| Jay Taragin | 53 | Chief Financial Officer |
| Jeremy Paul Abson | 52 | Director |
| Glenn R. August | 58 | Director |
| Mark Klein | 57 | Director |
| Malcolm S. McDermid | 41 | Director |
| Karen G. Mills | 66 | Director |
| Michael Eck | Director | |
| Bonnie Jonas | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Citigroup | Joint BR | 63,000,000 | units |
| Goldman Sachs | Joint BR | 34,000,000 | |
| Maxim | 3,000,000 | ||
| 100,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.